Sílvia Gel

Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression

Eugènia Negredo, Luís A. B. Cruz, Roger Paredes et al. · Clinical Infectious Diseases · 2002 · 170 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Antiretroviral Treatment Simplification With Nevirapine in Protease Inhibitor–Experienced Patients With HIV-Associated Lipodystrophy

Eugènia Negredo, Peré Domingo, Roger Paredes et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 168 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons

Margalida Rotger, Tracy R. Glass, Thomas Junier et al. · Clinical Infectious Diseases · 2013 · 74 citations · Full text

Life Sciences, Cardiology, Genetics +16

Reversal of HIV-1-associated osteoporosis with once-weekly alendronate.

Eugènia Negredo, Eva Martínez-López, Roger Paredes et al. · PubMed · 2005 · 68 citations

Medicine, Clinical Pharmacy, Bone Metabolism +15

Antiretroviral Treatment Simplification With Nevirapine in Protease Inhibitor–Experienced Patients With HIV-Associated Lipodystrophy

Eugènia Negredo, Peré Domingo, Roger Paredes et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 66 citations

Pharmacy, Pharmacology, Pharmacotherapy +17